Form 4 for IRD Opus Genetics, Inc.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-10 · accession 0000905148-26-000164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-13 | 2026-01-10 | IRD | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | F - Tax | $1.93 | -3,950 | 110.0K | -3% | -$7,624 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-10 | F | D | 3,950 | $1.93 | 110,018 | D | — | — |